BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37767786)

  • 1. Altered gut microbiome, bile acid composition and metabolome in sarcopenia in liver cirrhosis.
    Aliwa B; Horvath A; Traub J; Feldbacher N; Habisch H; Fauler G; Madl T; Stadlbauer V
    J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2676-2691. PubMed ID: 37767786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pegbelfermin selectively reduces secondary bile acid concentrations in patients with non-alcoholic steatohepatitis.
    Luo Y; Decato BE; Charles ED; Shevell DE; McNaney C; Shipkova P; Apfel A; Tirucherai GS; Sanyal AJ
    JHEP Rep; 2022 Jan; 4(1):100392. PubMed ID: 34977519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered metabolism of bile acids correlates with clinical parameters and the gut microbiota in patients with diarrhea-predominant irritable bowel syndrome.
    Wei W; Wang HF; Zhang Y; Zhang YL; Niu BY; Yao SK
    World J Gastroenterol; 2020 Dec; 26(45):7153-7172. PubMed ID: 33362374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of the fecal bile acid profile by gut microbiota in cirrhosis.
    Kakiyama G; Pandak WM; Gillevet PM; Hylemon PB; Heuman DM; Daita K; Takei H; Muto A; Nittono H; Ridlon JM; White MB; Noble NA; Monteith P; Fuchs M; Thacker LR; Sikaroodi M; Bajaj JS
    J Hepatol; 2013 May; 58(5):949-55. PubMed ID: 23333527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bile acids associate with specific gut microbiota, low-level alcohol consumption and liver fibrosis in patients with non-alcoholic fatty liver disease.
    Adams LA; Wang Z; Liddle C; Melton PE; Ariff A; Chandraratna H; Tan J; Ching H; Coulter S; de Boer B; Christophersen CT; O'Sullivan TA; Morrison M; Jeffrey GP
    Liver Int; 2020 Jun; 40(6):1356-1365. PubMed ID: 32243703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased bile acids in enterohepatic circulation by short-term calorie restriction in male mice.
    Fu ZD; Klaassen CD
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):680-90. PubMed ID: 24183703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The profile of bile acids and their sulfate metabolites in human urine and serum.
    Bathena SP; Mukherjee S; Olivera M; Alnouti Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Dec; 942-943():53-62. PubMed ID: 24212143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative profiling of 19 bile acids in rat plasma, liver, bile and different intestinal section contents to investigate bile acid homeostasis and the application of temporal variation of endogenous bile acids.
    Yang T; Shu T; Liu G; Mei H; Zhu X; Huang X; Zhang L; Jiang Z
    J Steroid Biochem Mol Biol; 2017 Sep; 172():69-78. PubMed ID: 28583875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biliary bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid.
    Combes B; Carithers RL; Maddrey WC; Munoz S; Garcia-Tsao G; Bonner GF; Boyer JL; Luketic VA; Shiffman ML; Peters MG; White H; Zetterman RK; Risser R; Rossi SS; Hofmann AF
    Hepatology; 1999 Jun; 29(6):1649-54. PubMed ID: 10347103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response.
    Shen Y; Wu SD; Chen Y; Li XY; Zhu Q; Nakayama K; Zhang WQ; Weng CZ; Zhang J; Wang HK; Wu J; Jiang W
    Gut Microbes; 2023; 15(1):2155018. PubMed ID: 36519342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dysregulated bile acid-gut microbiota axis contributes to obesity susceptibility.
    Wei M; Huang F; Zhao L; Zhang Y; Yang W; Wang S; Li M; Han X; Ge K; Qu C; Rajani C; Xie G; Zheng X; Zhao A; Bian Z; Jia W
    EBioMedicine; 2020 May; 55():102766. PubMed ID: 32408110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A possible role of chenodeoxycholic acid and glycine-conjugated bile acids in fibrotic steatohepatitis in a dietary rat model.
    Jia X; Suzuki Y; Naito H; Yetti H; Kitamori K; Hayashi Y; Kaneko R; Nomura M; Yamori Y; Zaitsu K; Kato M; Ishii A; Nakajima T
    Dig Dis Sci; 2014 Jul; 59(7):1490-501. PubMed ID: 24448653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive Analysis of Serum and Fecal Bile Acid Profiles and Interaction with Gut Microbiota in Primary Biliary Cholangitis.
    Chen W; Wei Y; Xiong A; Li Y; Guan H; Wang Q; Miao Q; Bian Z; Xiao X; Lian M; Zhang J; Li B; Cao Q; Fan Z; Zhang W; Qiu D; Fang J; Gershwin ME; Yang L; Tang R; Ma X
    Clin Rev Allergy Immunol; 2020 Feb; 58(1):25-38. PubMed ID: 30900136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of feeding bile acids and a bile acid sequestrant on hepatic bile acid composition in mice.
    Zhang Y; Klaassen CD
    J Lipid Res; 2010 Nov; 51(11):3230-42. PubMed ID: 20671298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered Microbiota Diversity and Bile Acid Signaling in Cirrhotic and Noncirrhotic NASH-HCC.
    Sydor S; Best J; Messerschmidt I; Manka P; Vilchez-Vargas R; Brodesser S; Lucas C; Wegehaupt A; Wenning C; Aßmuth S; Hohenester S; Link A; Faber KN; Moshage H; Cubero FJ; Friedman SL; Gerken G; Trauner M; Canbay A; Bechmann LP
    Clin Transl Gastroenterol; 2020 Mar; 11(3):e00131. PubMed ID: 32352707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-response of five bile acids on serum and liver bile Acid concentrations and hepatotoxicty in mice.
    Song P; Zhang Y; Klaassen CD
    Toxicol Sci; 2011 Oct; 123(2):359-67. PubMed ID: 21747115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bile acids contribute to the development of non-alcoholic steatohepatitis in mice.
    Gillard J; Clerbaux LA; Nachit M; Sempoux C; Staels B; Bindels LB; Tailleux A; Leclercq IA
    JHEP Rep; 2022 Jan; 4(1):100387. PubMed ID: 34825156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual bile acids have differential effects on bile acid signaling in mice.
    Song P; Rockwell CE; Cui JY; Klaassen CD
    Toxicol Appl Pharmacol; 2015 Feb; 283(1):57-64. PubMed ID: 25582706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut Microbiota Dysbiosis Is Associated with Altered Bile Acid Metabolism in Infantile Cholestasis.
    Wang Y; Gao X; Zhang X; Xiao Y; Huang J; Yu D; Li X; Hu H; Ge T; Li D; Zhang T
    mSystems; 2019 Dec; 4(6):. PubMed ID: 31848302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiota derived bile acid metabolites maintain the homeostasis of gut and systemic immunity.
    Su X; Gao Y; Yang R
    Front Immunol; 2023; 14():1127743. PubMed ID: 37256134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.